Search

everythinglearnresearchcommunity

for

Search:↓

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

MPZL3 is crucial for seborrheic dermatitis development.

Cinainu is effective and safe for treating children's alopecia areata.

Somatic BHD mutations are rare in Japanese renal tumors.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

QLT0267 stops hair follicle cell growth and movement.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

BFNB could be a promising treatment for hair growth.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Kerion cases had longer disease duration but responded well to antifungal treatments.

MPZL3 is important for controlling the hair growth cycle in mice and humans.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.